cutaneous T cell

Related by string. * Cutaneous : cutaneous melanoma . cutaneous manifestations . cutaneous leishmaniasis . cutaneous squamous cell carcinoma . cutaneous malignant melanoma . cutaneous T / TD . TS . Ting . TER . TED . T. : g t gold . g t Ag . & T . g t silver . Booker T. Washington . starter Ted Lilly / Cells . CELL . Cell . celled . CELLS : stem cell research . Q Cells AG . Fuel Cell . Q Cells SE . adult stem cells * *

Related by context. Frequent words. (Click for all words.) 69 metastatic renal cell carcinoma 69 chronic lymphocytic leukemia CLL 68 hormone refractory prostate cancer 68 hematologic malignancies 67 myelofibrosis 66 eltrombopag 66 relapsing remitting multiple sclerosis 66 CTCL 66 refractory multiple myeloma 66 B CLL 66 Torisel 65 chronic myeloid leukemia CML 65 BAY #-# 65 Clolar 65 hematological malignancies 65 unresectable 65 ZYBRESTAT 64 hematological cancers 64 ADVEXIN 64 vandetanib 64 TREANDA 64 castration resistant prostate cancer 63 vinorelbine 63 hepatocellular carcinoma HCC 63 pralatrexate 63 RG# [001] 63 sapacitabine 63 metastatic colorectal cancer 62 FOLOTYN 62 HRPC 62 Phase 2b clinical 62 Taxotere R 62 clofarabine 62 myelodysplastic syndromes 62 AP# [003] 62 T DM1 62 relapsing forms 62 mCRC 62 talactoferrin 62 eculizumab 62 HGS ETR1 62 NSCLC 62 lupus nephritis 61 MGCD# [001] 61 advanced NSCLC 61 resistant ovarian cancer 61 Perifosine 61 tamibarotene 61 Phase 2a trial 61 tesetaxel 61 ARCALYST 61 Phase III clinical 61 humanized monoclonal antibody 61 Cell Lung Cancer 61 azacitidine 61 systemic lupus erythematosus SLE 61 monotherapy 61 GRN#L 61 investigational compound 61 Marqibo 61 IMGN# 61 dasatinib 61 neuroendocrine tumors 61 Phase Ib 61 ZADAXIN 61 Actemra 60 acute myeloid leukemia AML 60 belinostat 60 ofatumumab 60 renal cell carcinoma 60 Zerenex 60 Pixantrone 60 Docetaxel 60 mixed dyslipidemia 60 metastatic melanoma 60 INCB# [002] 60 systemic lupus erythematosus 60 Phase 2a clinical 60 ENMD 60 ACTEMRA 60 Phase IIa trial 60 CA4P 60 myelodysplastic syndromes MDS 60 ZEVALIN 60 voreloxin 60 Vectibix 60 Cimzia ® 60 pirfenidone 60 solid tumors 60 Bevacizumab 60 cell malignancies 60 sorafenib 60 chronic angina 60 Rituximab 59 Marketing Authorization Application MAA 59 carfilzomib 59 blinatumomab 59 LymphoStat B 59 hepatocellular carcinoma 59 postherpetic neuralgia 59 ASA#

Back to home page